| Literature DB >> 19246756 |
Emma Lång1,2, Kristine Haugen1, Burkhard Fleckenstein3, Håvard Homberset2, Stephan A Frye1,2, Ole Herman Ambur1,2, Tone Tønjum1,2.
Abstract
Neisseria meningitidis, a causative agent of meningitis and septicaemia, expresses type IV pili, a feature correlating with the uptake of exogenous DNA from the environment by natural transformation. The outer membrane complex PilQ, through which pili are extruded and retracted, has previously been shown to bind DNA in its pore region. In order to further elucidate how DNA is transported across the membranes, we searched for DNA binding proteins within the meningococcal inner membrane. Inner membrane fractions from a panel of neisserial strains were subjected to a solid-phase overlay assay with DNA substrates, and MS was subsequently employed to identify proteins that bind DNA. A number of DNA binding components were detected, including the pilus biogenesis component PilG, the competence protein ComL, and the cell division ATP-binding protein FtsE, as well as two hypothetical proteins. The DNA binding activity of these components was not dependent on the presence of the neisserial DNA uptake sequence. Null mutants, corresponding to each of the proteins identified, were constructed to assess their phenotypes. Only mutants defective in pilus biogenesis were non-competent and non-piliated. The DNA binding activity of the pilus biogenesis components PilQ and PilG and the phenotypes of their respective null mutants suggest that these proteins are directly involved as players in natural transformation, and not only indirectly, through pilus biogenesis.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19246756 PMCID: PMC2885667 DOI: 10.1099/mic.0.022640-0
Source DB: PubMed Journal: Microbiology (Reading) ISSN: 1350-0872 Impact factor: 2.777
Bacterial strains and plasmids employed in this study
| H44/76 wild-type | Serogroup B, isolated in Norway, 1976 | |
| H44/76 ΔPilG | ||
| MC58 wild-type | Serogroup B, isolated in the UK, 1983 | |
| Z2491 wild-type | Serogroup A, isolated in Gambia, 1983 | |
| 8013 wild-type | Serogroup C | |
| M1080 wild-type | Serogroup B, isolated in the USA, 1969 | |
| M1080 ΔPilQ | M1080 strain with mTnCm#21 in | |
| M400 (M1080-A) | Derivative of M1080 with | |
| N400 wild-type | ||
| ER2566 | Expression strain with a chromosomal copy of the T7 RNA polymerase gene | New England Biolabs |
| XL-1 Blue | Stratagene | |
| p1080 | Plasmid containing an erythromycin-resistance gene inserted into | |
| pBSK+ | General cloning vector, Ampr | Stratagene |
*recA6 is an IPTG-inducible allele of recA.
DNA substrates employed in the study
DUS sequences are underlined.
| T1 | 5′ CAACAACAACAACA | +, 10 bp |
| T3 | 5′ CAACAACAACAACAGGCCTGTCATCCAAACTGACAGGCCAACAACAACAACA 3′ | − |
| HH8 | 5′ GTTGTTGTTGTT | +, 12 bp |
| T1T2 | 5′ CAACAACAACAACA | +, 10 bp |
| 5′ TGTTGTTGTTGTTGCCGTCTGAATTTGG | ||
| T3T4 | 5′ CAACAACAACAACAGGCCTGTCATCCAAACTGACAGGCCAACAACAACAACA 3′ | − |
| 5′ TGTTGTTGTTGTTGGCCTGTCATTTTGGATGACAGGCCTGTTGTTGTTGTTG 3′ | ||
| HH7,HH8 | 5′ AACAACAACAA | +, 12 bp |
| 5′ GTTGTTGTTGTTTTCAGACGGCATGTTGG |
Primers employed in construction of mutants
Restriction sites are underlined.
| KH83 | Forward | GC | |
| KH10 | Reverse | GC | |
| KH11 | Reverse | GC | |
| KH12 | Forward | GC | |
| KH45 | Forward | GC | |
| KH46 | Reverse | GC | |
| KH47 | Reverse | GC | |
| KH48 | Forward | GC | |
| KH82 | Forward | GC | |
| KH6 | Reverse | GC | |
| KH7 | Reverse | GC | |
| KH8 | Forward | GC | |
| KH13 | Forward | GC | |
| KH14 | Reverse | GC | |
| KH15 | Reverse | GC | |
| KH16 | Forward | GC | |
| KH81 | Reverse | GC | |
| KH2 | Forward | GC | |
| KH3 | Forward | GC | |
| KH4 | Reverse | GC | |
| KH84 | Reverse | GC | |
| KH18 | Forward | GC | |
| KH19 | Forward | GC | |
| KH20 | Reverse | GC | |
Fig. 1.Identification of PilG in the inner membrane (IM). Immunoblotting of meningococcal membrane fractions localizes the PilG protein in the IM of N. meningitidis. Lanes: 1, H44/76 wild-type (wt) IM; 2, H44/76 ΔPilG IM; 3, Z2491 wt IM; 4, M1080 wt IM; 5, H44/76 wt outer membrane. The positions of the 37 and 50 kDa size standards are shown on the left. The arrow on the right indicates the position of the PilG protein.
Fig. 2.Detection of DNA binding components. Solid-phase overlay assay (South-western analysis) of neisserial inner membrane fractions with biotin-labelled DNA substrates was performed. (a) Identification of PilQ, Omp85, PilG, NMB0086, ComL, FtsE and NMB0478 in the inner membrane fraction of N. meningitidis strain H44/76. (b) Identification of PilQ, Omp85, PilG and H.8 in the inner membrane fraction of N. meningitidis strain 8013. The DNA substrates depicted were ssDNA substrate T1 (a) and T3 (b) with and without the 10 bp DUS, respectively. The positions of the size standards (kDa) are shown on the left.
Phenotypic traits of null mutants corresponding to the DNA binding proteins identified by solid-phase overlay assay and MS analysis
| NMB0007 FtsE DUS− | ATPase activity, cell division | agg+ | wt‡ | Yes |
| NMB0703 ComL DUS− | Competence, peptidoglycan function | Not viable | Not viable | Not viable |
| NMB0478 hypothetical protein DUS+ | Unknown | agg+ | wt | Yes |
| NMB0086 hypothetical protein DUS+ | Unknown | agg+ | wt | Yes |
| NMB0333 PilG DUS− | Pilus biogenesis? | agg− | Absent | Non-competent ( |
| NMB1812 PilQ DUS− | Outer membrane pore, pilus extrusion transformation | agg− | Absent | Non-competent ( |
| NMB1533 H.8 DUS− | Iron–sulfur binding? | agg+, smaller than wt | wt | Yes |
| NMB0182 Omp85 DUS− | Cell envelope biogenesis | Not viable | Not viable | Not viable |
*The presence/absence of the DUS is given as DUS+/DUS−.
†Colony morphology is described as agglutinating (agg+) or non-agglutinating (agg−).
‡wt, Wild-type levels.
Fig. 3.PilG binds DNA without DUS specificity. Solid-phase overlay assay (South-western analysis) shows DNA binding activity of recombinant PilG protein and the PilG protein from the meningococcal inner membrane fraction. No DUS specificity was observed and the position of the PilG protein is indicated by the arrow. (a) DNA binding activity of full-length recombinant PilG. Lanes: 1, ssDNA substrate (T1) with 10 bp DUS; 2, dsDNA substrate (T1T2) with 10 bp DUS; 3, ssDNA substrate (T3) without DUS; 4, dsDNA substrate (T3T4) without DUS; 5, ssDNA substrate (HH8) with 12 bp DUS; 6, dsDNA substrate (HH7,HH8) with 12 bp DUS. (b) Identification of PilG DNA binding activity in the meningococcal inner membrane fraction using ssDNA substrate (T1). Lane 1, H44/76 wild-type; lane 2, H44/76 ΔPilG. The positions of the size standards (kDa) are shown on the left.